Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 98 Thousand USD | 653.85% |
| 2022 | 13 Thousand USD | -83.95% |
| 2021 | 81 Thousand USD | -20.59% |
| 2020 | 102 Thousand USD | 183.33% |
| 2019 | 36 Thousand USD | -36.84% |
| 2018 | 57 Thousand USD | -76.64% |
| 2017 | 244 Thousand USD | -59.67% |
| 2016 | 605 Thousand USD | -0.17% |
| 2015 | 606 Thousand USD | -26.37% |
| 2014 | 823 Thousand USD | -30.2% |
| 2013 | 1.17 Million USD | -65.43% |
| 2012 | 3.41 Million USD | -5.2% |
| 2011 | 3.59 Million USD | 6.93% |
| 2010 | 3.36 Million USD | 117.03% |
| 2009 | 1.55 Million USD | 17.69% |
| 2008 | 1.31 Million USD | 27.0% |
| 2007 | 1.03 Million USD | 6.14% |
| 2006 | 977 Thousand USD | -0.61% |
| 2005 | 983 Thousand USD | -8.39% |
| 2004 | 1.07 Million USD | -32.35% |
| 2003 | 1.58 Million USD | -58.24% |
| 2002 | 3.79 Million USD | 54.52% |
| 2001 | 2.45 Million USD | -50.52% |
| 2000 | 4.96 Million USD | 50.55% |
| 1999 | 3.3 Million USD | 135.71% |
| 1998 | 1.4 Million USD | 55.56% |
| 1997 | 900 Thousand USD | 80.0% |
| 1996 | 500 Thousand USD | -57.63% |
| 1995 | 1.18 Million USD | 883.33% |
| 1994 | 120 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - USD | -100.0% |
| 2024 Q1 | 6000.00 USD | -81.25% |
| 2023 Q3 | - USD | -100.0% |
| 2023 FY | 98 Thousand USD | 653.85% |
| 2023 Q1 | 22 Thousand USD | 120.0% |
| 2023 Q4 | 32 Thousand USD | 0.0% |
| 2023 Q2 | 44 Thousand USD | 100.0% |
| 2022 FY | 13 Thousand USD | -83.95% |
| 2022 Q3 | 3000.00 USD | -40.0% |
| 2022 Q2 | 5000.00 USD | 0.0% |
| 2022 Q1 | 5000.00 USD | -91.67% |
| 2022 Q4 | 10 Thousand USD | 233.33% |
| 2021 Q3 | 19 Thousand USD | 850.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q2 | 2000.00 USD | 0.0% |
| 2021 Q4 | 60 Thousand USD | 215.79% |
| 2021 FY | 81 Thousand USD | -20.59% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 25 Thousand USD | -67.53% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | 77 Thousand USD | 0.0% |
| 2020 FY | 102 Thousand USD | 183.33% |
| 2019 Q1 | 18 Thousand USD | -57.14% |
| 2019 Q3 | 1000.00 USD | 0.0% |
| 2019 Q4 | 16 Thousand USD | 1500.0% |
| 2019 Q2 | 1000.00 USD | -94.44% |
| 2019 FY | 36 Thousand USD | -36.84% |
| 2018 Q1 | 4000.00 USD | -96.26% |
| 2018 Q4 | 42 Thousand USD | 2000.0% |
| 2018 FY | 57 Thousand USD | -76.64% |
| 2018 Q2 | 8000.00 USD | 100.0% |
| 2018 Q3 | 2000.00 USD | -75.0% |
| 2017 Q4 | 107 Thousand USD | 224.24% |
| 2017 FY | 244 Thousand USD | -59.67% |
| 2017 Q1 | 21 Thousand USD | -82.35% |
| 2017 Q2 | 87 Thousand USD | 314.29% |
| 2017 Q3 | 33 Thousand USD | -62.07% |
| 2016 FY | 605 Thousand USD | -0.17% |
| 2016 Q1 | 262 Thousand USD | 4.8% |
| 2016 Q3 | 95 Thousand USD | -26.36% |
| 2016 Q4 | 119 Thousand USD | 25.26% |
| 2016 Q2 | 129 Thousand USD | -50.76% |
| 2015 Q1 | 142 Thousand USD | -23.24% |
| 2015 FY | 606 Thousand USD | -26.37% |
| 2015 Q2 | 103 Thousand USD | -27.46% |
| 2015 Q3 | 102 Thousand USD | -0.97% |
| 2015 Q4 | 250 Thousand USD | 145.1% |
| 2014 FY | 823 Thousand USD | -30.2% |
| 2014 Q2 | 212 Thousand USD | 50.35% |
| 2014 Q1 | 141 Thousand USD | -64.66% |
| 2014 Q3 | 284 Thousand USD | 33.96% |
| 2014 Q4 | 185 Thousand USD | -34.86% |
| 2013 FY | 1.17 Million USD | -65.43% |
| 2013 Q4 | 399 Thousand USD | 177.08% |
| 2013 Q3 | 144 Thousand USD | -57.4% |
| 2013 Q2 | 338 Thousand USD | 13.04% |
| 2013 Q1 | 299 Thousand USD | -70.45% |
| 2012 Q1 | 718 Thousand USD | -19.87% |
| 2012 Q4 | 1.01 Million USD | 37.5% |
| 2012 Q3 | 736 Thousand USD | -22.03% |
| 2012 Q2 | 944 Thousand USD | 31.48% |
| 2012 FY | 3.41 Million USD | -5.2% |
| 2011 Q4 | 896 Thousand USD | -12.24% |
| 2011 Q2 | 913 Thousand USD | 19.04% |
| 2011 FY | 3.59 Million USD | 6.93% |
| 2011 Q3 | 1.02 Million USD | 11.83% |
| 2011 Q1 | 767 Thousand USD | -27.78% |
| 2010 Q3 | 676 Thousand USD | -16.02% |
| 2010 Q1 | 821 Thousand USD | 49.27% |
| 2010 FY | 3.36 Million USD | 117.03% |
| 2010 Q2 | 805 Thousand USD | -1.95% |
| 2010 Q4 | 1.06 Million USD | 57.1% |
| 2009 Q4 | 550 Thousand USD | -4.68% |
| 2009 FY | 1.55 Million USD | 17.69% |
| 2009 Q2 | 242 Thousand USD | 33.7% |
| 2009 Q3 | 577 Thousand USD | 138.43% |
| 2009 Q1 | 181 Thousand USD | -10.4% |
| 2008 Q2 | 449 Thousand USD | 38.15% |
| 2008 Q1 | 325 Thousand USD | -3.56% |
| 2008 FY | 1.31 Million USD | 27.0% |
| 2008 Q4 | 202 Thousand USD | -40.59% |
| 2008 Q3 | 340 Thousand USD | -24.28% |
| 2007 FY | 1.03 Million USD | 6.14% |
| 2007 Q4 | 337 Thousand USD | 67.66% |
| 2007 Q3 | 201 Thousand USD | -35.99% |
| 2007 Q2 | 314 Thousand USD | 24.6% |
| 2007 Q1 | 252 Thousand USD | 35.48% |
| 2006 Q3 | 457 Thousand USD | 120.77% |
| 2006 Q4 | 186 Thousand USD | -59.3% |
| 2006 Q2 | 207 Thousand USD | 62.99% |
| 2006 FY | 977 Thousand USD | -0.61% |
| 2006 Q1 | 127 Thousand USD | -25.73% |
| 2005 FY | 983 Thousand USD | -8.39% |
| 2005 Q1 | 369 Thousand USD | -7.75% |
| 2005 Q2 | 269 Thousand USD | -27.1% |
| 2005 Q3 | 174 Thousand USD | -35.32% |
| 2005 Q4 | 171 Thousand USD | -1.72% |
| 2004 FY | 1.07 Million USD | -32.35% |
| 2004 Q1 | 125 Thousand USD | -72.22% |
| 2004 Q2 | 272 Thousand USD | 117.6% |
| 2004 Q3 | 276 Thousand USD | 1.47% |
| 2004 Q4 | 400 Thousand USD | 44.93% |
| 2003 Q1 | 801 Thousand USD | 3.49% |
| 2003 FY | 1.58 Million USD | -58.24% |
| 2003 Q4 | 450 Thousand USD | 115.31% |
| 2003 Q3 | 209 Thousand USD | 65.87% |
| 2003 Q2 | 126 Thousand USD | -84.27% |
| 2002 Q3 | 1.59 Million USD | 106.46% |
| 2002 FY | 3.79 Million USD | 54.52% |
| 2002 Q2 | 774 Thousand USD | 18.71% |
| 2002 Q1 | 652 Thousand USD | 3.16% |
| 2002 Q4 | 774 Thousand USD | -51.56% |
| 2001 FY | 2.45 Million USD | -50.52% |
| 2001 Q3 | 570 Thousand USD | -10.24% |
| 2001 Q2 | 635 Thousand USD | 2.25% |
| 2001 Q1 | 621 Thousand USD | -75.9% |
| 2001 Q4 | 632 Thousand USD | 10.88% |
| 2000 Q1 | 1.06 Million USD | -11.58% |
| 2000 FY | 4.96 Million USD | 50.55% |
| 2000 Q4 | 2.57 Million USD | 387.15% |
| 2000 Q3 | 529 Thousand USD | -33.96% |
| 2000 Q2 | 801 Thousand USD | -24.51% |
| 1999 Q1 | 400 Thousand USD | -33.33% |
| 1999 Q3 | 1.4 Million USD | 366.67% |
| 1999 FY | 3.3 Million USD | 135.71% |
| 1999 Q4 | 1.2 Million USD | -14.29% |
| 1999 Q2 | 300 Thousand USD | -25.0% |
| 1998 FY | 1.4 Million USD | 55.56% |
| 1998 Q4 | 600 Thousand USD | 50.0% |
| 1998 Q3 | 400 Thousand USD | 0.0% |
| 1998 Q2 | 400 Thousand USD | 300.0% |
| 1998 Q1 | 100 Thousand USD | -80.0% |
| 1997 Q1 | 100 Thousand USD | -75.0% |
| 1997 FY | 900 Thousand USD | 80.0% |
| 1997 Q2 | 200 Thousand USD | 100.0% |
| 1997 Q3 | 100 Thousand USD | -50.0% |
| 1997 Q4 | 500 Thousand USD | 400.0% |
| 1996 FY | 500 Thousand USD | -57.63% |
| 1996 Q4 | 400 Thousand USD | 700.0% |
| 1996 Q3 | 50 Thousand USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 FY | 1.18 Million USD | 883.33% |
| 1994 FY | 120 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | 86.288% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | 89.0% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 96.522% |
| Avitar, Inc. | 3.1 Million USD | 96.845% |
| AVITA Medical, Inc. | 50.56 Million USD | 99.806% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.988% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -13.151% |
| QHSLab, Inc. | 1.4 Million USD | 93.045% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.988% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 99.814% |
| Escalon Medical Corp. | 11.98 Million USD | 99.182% |
| Aurora Spine Corporation | 14.52 Million USD | 99.325% |
| BrainsWay Ltd. | 31.78 Million USD | 99.692% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | 61.927% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 99.857% |
| Vivos Inc. | 19.5 Thousand USD | -402.564% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.99% |
| Kelyniam Global, Inc. | 2.67 Million USD | 96.333% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | 51.894% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -15.998% |
| Nanomix Corporation | 15.45 Thousand USD | -534.304% |
| Theraclion SA | 1.82 Million USD | 94.622% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 85.186% |
| Positron Corporation | 734.66 Thousand USD | 86.661% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 92.734% |
| Lombard Medical, Inc. | 12.16 Million USD | 99.195% |
| ALR Technologies Inc. | 7468.00 USD | -1212.266% |
| Stratec SE | 289.14 Million USD | 99.966% |
| Vycor Medical, Inc. | 1.46 Million USD | 93.29% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 75.715% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 99.52% |
| VMS Rehab Systems, Inc. | 71.70 USD | -136580.614% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 86.402% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 96.556% |
| Urologix, Inc. | 14.23 Million USD | 99.312% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 97.033% |
| SS Innovations International, Inc. | 5.87 Million USD | 98.333% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -143.933% |
| Smith & Nephew plc | 5.68 Billion USD | 99.998% |
| NIOX Group Plc | 46.84 Million USD | 99.791% |
| Fuse Medical, Inc. | 16.11 Million USD | 99.392% |
| Broncus Holding Corporation | 10.25 Million USD | 99.044% |
| Brain Scientific Inc. | 214.56 Thousand USD | 54.326% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 95.045% |
| Health Logic Interactive Inc. | - USD | -Infinity% |